ArticlePharmaceuticals (Basel, Switzerland)2022

Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities.

Salma M Khirallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.